27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

ZLAB Insider Trading (Zai Lab)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.26%

Insider Buying (Last 12 Months): $285,440.00

Insider Selling (Last 12 Months): $20,898,308.03

Zai Lab Insider Trading History Chart

Zai Lab Share Price & Price History

^$45.18

▲ +0.45 (1.01%)

As of 08/11/2022 03:04 PM ET

Days: 30 | 90 | 365

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

Zai Lab Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/4/2022	John D. Diekman	Director	Sell	1,000	$50.17	$50,170.00
1/20/2022	William Lis	Director	Sell	1,926	$53.40	$102,848.40
12/8/2021	Peter Wirth	Director	Buy	4,000	$71.36	$285,440.00
11/5/2021	John D. Diekman	Director	Sell	1,000	$91.65	$91,650.00
10/28/2021	Tao Fu	COO	Sell	10,000	$105.00	$1,050,000.00
10/14/2021	Tao Fu	COO	Sell	10,000	$102.68	$1,026,800.00
9/30/2021	Tao Fu	COO	Sell	10,000	$106.73	$1,067,300.00
9/15/2021	Tao Fu	COO	Sell	9,900	$127.86	$1,265,814.00	217,500
9/7/2021	Harald Reinhart	Insider	Sell	10,000	$150.93	$1,509,300.00
9/7/2021	Ying Du	CEO	Sell	29,785	$150.73	$4,489,493.05	1,038,056
9/3/2021	Ying Du	CEO	Sell	24,145	$145.04	$3,501,990.80	1,119,764
9/1/2021	Ying Du	CEO	Sell	28,443	$146.46	$4,165,761.78
8/25/2021	Tao Fu	COO	Sell	10,000	$143.03	$1,430,300.00	217,000
8/24/2021	Harald Reinhart	Insider	Sell	8,000	$143.36	$1,146,880.00
8/5/2021	John D. Diekman	Director	Sell	1,000	$149.50	$149,500.00	61,852
8/2/2021	Ying Du	CEO	Sell	84,894	$144.56	$12,272,276.64
7/15/2021	Tao Fu	COO	Sell	10,000	$172.82	$1,728,200.00
7/13/2021	Harald Reinhart	Insider	Sell	8,000	$169.92	$1,359,360.00
7/1/2021	Ying Du	CEO	Sell	83,858	$175.70	$14,733,850.60
6/16/2021	Harald Reinhart	Insider	Sell	8,000	$162.71	$1,301,680.00	8,000
6/15/2021	Tao Fu	COO	Sell	10,000	$165.28	$1,652,800.00	217,000
6/1/2021	William Ki Chul Cho	CFO	Sell	8,584	$180.12	$1,546,150.08	51,416
6/1/2021	Ying Du	CEO	Sell	101,648	$176.19	$17,909,361.12	1,119,764
5/26/2021	Tao Fu	COO	Sell	10,000	$159.40	$1,594,000.00	217,000
5/25/2021	Harald Reinhart	Insider	Sell	8,000	$161.66	$1,293,280.00	8,000
5/5/2021	John D. Diekman	Director	Sell	1,000	$153.62	$153,620.00	62,852
5/3/2021	Ying Du	CEO	Sell	62,164	$161.57	$10,043,837.48	889,331
4/21/2021	Harald Reinhart	Insider	Sell	16,000	$156.10	$2,497,600.00	8,000
4/19/2021	Tao Fu	COO	Sell	10,000	$162.91	$1,629,100.00	217,000
4/7/2021	Ying Du	CEO	Sell	21,936	$134.42	$2,948,637.12	1,008,653
4/5/2021	Ying Du	CEO	Sell	50,784	$126.19	$6,408,432.96	1,008,653
3/12/2021	Kai-Xian Chen	Director	Sell	4,302	$142.53	$613,164.06	24,662

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Zai Lab (NASDAQ:ZLAB)

72.65% of Zai Lab stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Zai Lab Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/11/2022	UBS Group AG	152,382	$5.29M	0.0%	+1.3%	0.156%
8/11/2022	Platinum Investment Management Ltd.	147,272	$5.11M	0.2%	+41.3%	0.150%
8/11/2022	Alps Advisors Inc.	58,080	$2.01M	0.0%	N/A	0.059%
8/11/2022	JPMorgan Chase & Co.	239,810	$8.32M	0.0%	-17.5%	0.245%
8/10/2022	California Public Employees Retirement System	110,797	$3.84M	0.0%	-4.2%	0.113%
8/9/2022	Mitsubishi UFJ Trust & Banking Corp	22,578	$0.78M	0.0%	+2.4%	0.023%
8/9/2022	Swiss National Bank	219,771	$7.62M	0.0%	+5.0%	0.224%
8/9/2022	Pictet Asset Management SA	81,812	$2.84M	0.0%	-9.0%	0.084%
8/9/2022	Shell Asset Management Co.	17,962	$0.62M	0.0%	-1.6%	0.018%
8/8/2022	Baillie Gifford & Co.	737,152	$25.47M	0.0%	-73.0%	0.753%
8/6/2022	Segantii Capital Management Ltd	2,241,274	$77.73M	1.9%	-0.5%	2.289%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	88,740	$3.08M	0.0%	+51.6%	0.091%
8/5/2022	abrdn plc	18,765	$0.65M	0.0%	+125.4%	0.019%
8/4/2022	Aviva PLC	44,770	$1.55M	0.0%	+24.8%	0.046%
8/4/2022	TD Asset Management Inc.	38,385	$1.33M	0.0%	-10.3%	0.039%
8/3/2022	Integral Health Asset Management LLC	156,554	$5.43M	1.1%	+108.7%	0.160%
8/3/2022	DekaBank Deutsche Girozentrale	29,550	$0.99M	0.0%	-1.1%	0.030%
8/3/2022	Zeal Asset Management Ltd	288,208	$9.68M	19.9%	-18.1%	0.294%
8/3/2022	Handelsbanken Fonder AB	53,400	$1.85M	0.0%	+39.8%	0.055%
8/1/2022	Profund Advisors LLC	13,470	$0.47M	0.0%	+7.1%	0.014%
7/29/2022	SG Americas Securities LLC	44,062	$1.53M	0.0%	+503.3%	0.045%
7/29/2022	Russell Investments Group Ltd.	310,553	$10.77M	0.0%	+3,266.8%	0.317%
7/29/2022	Asset Management One Co. Ltd.	17,008	$0.59M	0.0%	+7.6%	0.017%
7/28/2022	Privium Fund Management B.V.	248,357	$8.61M	2.9%	+9.5%	0.254%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	158,009	$5.48M	0.0%	-6.1%	0.161%
7/26/2022	Sumitomo Mitsui Trust Holdings Inc.	199,482	$6.92M	0.0%	+11.6%	0.204%
7/22/2022	Genesis Investment Management LLP	1,610,174	$55.84M	5.0%	+96.3%	1.645%
7/18/2022	Connective Portfolio Management LLC	20,000	$0.69M	1.2%	N/A	0.020%
7/13/2022	E Fund Management Hong Kong Co. Ltd.	59,590	$2.07M	1.4%	+31.8%	0.061%
7/7/2022	AdvisorNet Financial Inc	1,600	$55K	0.0%	+100.0%	0.002%
6/7/2022	Bank of America Corp DE	132,963	$5.85M	0.0%	+5.4%	0.136%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	168,200	$7.40M	0.0%	+26.6%	0.172%
5/20/2022	International Biotechnology Trust PLC	78,958	$16.96M	3.8%	+102.7%	0.081%
5/20/2022	The Manufacturers Life Insurance Company	45,309	$2.04M	0.0%	+248.5%	0.046%
5/19/2022	Capital World Investors	1,848,858	$81.33M	0.0%	-54.7%	1.888%
5/19/2022	Capital International Sarl	152,323	$6.70M	0.3%	N/A	0.156%
5/19/2022	Capital Group International Inc. CA	866,477	$38.11M	0.4%	+1,256.9%	0.885%
5/19/2022	Capital International Investors	979,270	$43.07M	0.0%	N/A	1.000%
5/18/2022	BNP Paribas Arbitrage SA	135,453	$5.96M	0.0%	-28.4%	0.138%
5/17/2022	Alyeska Investment Group L.P.	90,000	$3.96M	0.0%	+500.0%	0.092%
5/17/2022	Polar Capital Holdings Plc	132,382	$5.82M	0.0%	+1.6%	0.135%
5/17/2022	Quantbot Technologies LP	8,729	$0.38M	0.0%	+481.9%	0.009%
5/17/2022	Rock Springs Capital Management LP	1,205,900	$53.04M	1.3%	+2.1%	1.232%
5/17/2022	Gilder Gagnon Howe & Co. LLC	1,054,901	$46.40M	0.4%	-3.0%	1.077%
5/16/2022	California State Teachers Retirement System	4,647	$0.20M	0.0%	-72.7%	0.005%
5/16/2022	Goldman Sachs Group Inc.	316,603	$13.92M	0.0%	-26.6%	0.328%
5/16/2022	Viking Global Investors LP	3,133,297	$137.80M	0.6%	+3.8%	3.250%
5/16/2022	Woodline Partners LP	291,517	$12.82M	0.2%	N/A	0.302%
5/16/2022	Wellington Management Group LLP	1,120,954	$49.30M	0.0%	-68.4%	1.163%
5/16/2022	State Street Corp	1,426,650	$62.74M	0.0%	-9.2%	1.480%
5/16/2022	Invesco Ltd.	8,258,118	$363.19M	0.1%	+13.9%	8.566%
5/16/2022	UBS Group AG	150,377	$6.61M	0.0%	-33.9%	0.156%
5/16/2022	Hsbc Holdings PLC	95,653	$4.21M	0.0%	+32.2%	0.099%
5/13/2022	Northern Trust Corp	180,756	$7.95M	0.0%	-2.8%	0.187%
5/13/2022	Charles Schwab Investment Management Inc.	77,656	$3.42M	0.0%	-1.8%	0.081%
5/13/2022	Caisse DE Depot ET Placement DU Quebec	14,232	$0.63M	0.0%	+7.6%	0.015%
5/13/2022	Clearbridge Investments LLC	445,576	$19.60M	0.0%	+7.1%	0.462%
5/13/2022	First Trust Advisors LP	10,713	$0.47M	0.0%	-4.4%	0.011%
5/13/2022	Prudential Financial Inc.	18,000	$0.79M	0.0%	N/A	0.019%
5/13/2022	Bridgewater Associates LP	353,968	$15.57M	0.1%	+80.5%	0.367%
5/13/2022	Vanguard Group Inc.	2,255,435	$99.20M	0.0%	+2.5%	2.339%
5/13/2022	Platinum Investment Management Ltd.	104,205	$4.58M	0.1%	-25.9%	0.108%
5/13/2022	Allianz Asset Management GmbH	267,098	$11.75M	0.0%	-9.4%	0.277%
5/13/2022	Canada Pension Plan Investment Board	69,480	$3.06M	0.0%	N/A	0.072%
5/13/2022	Aviva PLC	35,870	$1.58M	0.0%	+1.1%	0.037%
5/13/2022	Atika Capital Management LLC	235,000	$10.34M	0.9%	-13.9%	0.244%
5/13/2022	Vontobel Holding Ltd.	4,609	$0.21M	0.0%	N/A	0.005%
5/12/2022	Integral Health Asset Management LLC	75,000	$3.30M	0.9%	N/A	0.078%
5/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	35,511	$1.56M	0.0%	+11.7%	0.037%
5/12/2022	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	7,028	$0.31M	0.0%	N/A	0.007%
5/12/2022	Great West Life Assurance Co. Can	76,031	$3.48M	0.0%	-11.9%	0.079%
5/12/2022	APG Asset Management N.V.	8,727	$0.35M	0.0%	-5.4%	0.009%
5/12/2022	BlackRock Inc.	3,924,215	$172.59M	0.0%	+6.3%	4.070%
5/12/2022	Triatomic Management LP	55,996	$2.46M	2.0%	+107.4%	0.058%
5/12/2022	Capital Fund Management S.A.	16,007	$0.70M	0.0%	-72.6%	0.017%
5/12/2022	Citigroup Inc.	124,217	$5.46M	0.0%	+237.4%	0.129%
5/12/2022	Mitsubishi UFJ Trust & Banking Corp	22,050	$0.97M	0.0%	-2.3%	0.023%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	58,545	$2.58M	0.0%	-45.1%	0.061%
5/11/2022	Bank of New York Mellon Corp	73,100	$3.22M	0.0%	-1.2%	0.076%
5/11/2022	Krane Funds Advisors LLC	37,449	$1.65M	0.1%	+9.7%	0.039%
5/11/2022	Handelsbanken Fonder AB	38,200	$1.68M	0.0%	+6.1%	0.040%
5/11/2022	JPMorgan Chase & Co.	290,749	$12.79M	0.0%	-30.9%	0.302%
5/11/2022	Jennison Associates LLC	1,205,378	$53.01M	0.0%	+5,418.6%	1.250%
5/10/2022	Sectoral Asset Management Inc.	12,000	$0.53M	0.1%	+33.3%	0.012%
5/10/2022	Profund Advisors LLC	12,580	$0.55M	0.0%	+16.9%	0.013%
5/10/2022	ProShare Advisors LLC	7,312	$0.32M	0.0%	-26.0%	0.008%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	168,200	$7.40M	0.0%	+26.6%	0.174%
5/10/2022	B. Metzler seel. Sohn & Co. AG	5,702	$0.25M	0.0%	-14.9%	0.006%
5/10/2022	Privium Fund Management B.V.	226,752	$9.97M	2.2%	+4.6%	0.235%
5/9/2022	Swiss National Bank	209,271	$9.20M	0.0%	+14.4%	0.217%
5/9/2022	Teacher Retirement System of Texas	96,971	$4.27M	0.0%	+62.1%	0.101%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	29,682	$1.31M	0.0%	+38.6%	0.031%
5/6/2022	Zeal Asset Management Ltd	351,829	$15.23M	19.9%	+387.1%	0.365%
5/5/2022	Aigen Investment Management LP	5,502	$0.24M	0.0%	+56.0%	0.006%
5/5/2022	Baillie Gifford & Co.	2,727,210	$119.94M	0.1%	-46.9%	2.829%
5/4/2022	California Public Employees Retirement System	115,616	$5.09M	0.0%	-5.1%	0.120%
5/4/2022	Shell Asset Management Co.	18,262	$0.80M	0.0%	-12.9%	0.019%
4/29/2022	SG Americas Securities LLC	7,304	$0.32M	0.0%	-76.8%	0.008%
4/29/2022	Brilliance Asset Management Ltd.	1,631,887	$71.77M	28.2%	-50.9%	1.693%
4/29/2022	Tree Line Advisors Hong Kong Ltd.	460,000	$20.23M	12.0%	-23.3%	0.477%

Data available starting January 2016

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, pancreatic cancer, and other solid tumors; and Bemarituzumab to treat gastric and gastroesophageal junction cancer. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; Tebotelimab, a tetravalent IgG4 monoclonal antibody; Retifanlimab that inhibits interactions between PD-1 and its ligands; ZL-2309, an orally active, selective, and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor; ZL-1201, a humanized IgG4 monoclonal antibody; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; KarXT for the treatment of psychiatric and neurological conditions; ZL-2313, an investigational inhibitor of triple-mutant EGFR harboring; ZL-2314, an investigational inhibitor of double-mutant EGFR harboring; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China.

Today's Range

Now: $45.18

$45.04

$46.41

50 Day Range

MA: $36.16

$23.14

$47.08

52 Week Range

Now: $45.18

$22.51

$153.30

Volume

13,139 shs

Average Volume

444,042 shs

Market Capitalization

$4.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.06

Who are the company insiders with the largest holdings of Zai Lab?: Zai Lab's top insider shareholders include:
Ying Du (CEO)
Tao Fu (COO)
John D Diekman (Director)
John D Diekman (Director)
William Ki Chul Cho (CFO)
Kai-Xian Chen (Director)
Harald Reinhart (Insider)
Peter Wirth (Director)
William Lis (Director)
Learn More about top insider investors at Zai Lab.
Who are the major institutional investors of Zai Lab?: Zai Lab's top institutional shareholders include:
Segantii Capital Management Ltd — 2.29%
Genesis Investment Management LLP — 1.64%
Baillie Gifford & Co. — 0.75%
Deutsche Bank AG — 0.40%
Russell Investments Group Ltd. — 0.32%
Zeal Asset Management Ltd — 0.29%
Learn More about top institutional investors of Zai Lab stock.
Which major investors are selling Zai Lab stock?: Within the previous quarter, ZLAB stock was sold by these institutional investors:
Baillie Gifford & Co.
Zeal Asset Management Ltd
JPMorgan Chase & Co.
Segantii Capital Management Ltd
Mirae Asset Global Investments Co. Ltd.
Pictet Asset Management SA
California Public Employees Retirement System
TD Asset Management Inc.
During the previous year, company insiders that have sold Zai Lab company stock include:
Ying Du (CEO)
Tao Fu (COO)
John D Diekman (Director)
John D Diekman (Director)
William Ki Chul Cho (CFO)
Learn More investors selling Zai Lab stock.
Which major investors are buying Zai Lab stock?: Within the previous quarter, ZLAB stock was bought by institutional investors including:
Genesis Investment Management LLP
Russell Investments Group Ltd.
Integral Health Asset Management LLC
Healthcare of Ontario Pension Plan Trust Fund
Alps Advisors Inc.
Platinum Investment Management Ltd.
SG Americas Securities LLC
Connor Clark & Lunn Investment Management Ltd.

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!